Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan augmentation therapy for obsessive compulsive disorder
IRCT20221227056943N1Phase 4Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dextromethorphan in obsessive compulsive disorder (OCD), sponsored by Zanjan University of Medical Sciences. Started Jan 2023; status: completed.
02
Drugs
dextromethorphan
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT20221227056943N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221227056943N1.